ARTICLES LIST

 

Total Results: 16203

Media ID Source Name Media Type Language Media Name Media Description Keywords Keywords Link to Article
916 Centers for Disease Control and Prevention Html en Interim Estimates of 2013-14 Seasonal Influenza VaccineEffectiveness - United States, February 2014 Brendan Flannery, PhD1, Swathi N. Thaker, PhD1, Jessie Clippard, MPH1, Arnold S. Monto, MD2, Suzanne E.
influenza0.910213
U.S. Influenza Vaccine0.654703
influenza infection0.550936
United States0.538934
influenza pandemic viruses0.593334
influenza pH1N1 virus0.57366
inactivated influenza vaccines0.55073
pH1N1 influenza viruses0.579116
seasonal influenza vaccination0.630938
Influenza vaccination coverage0.588032
influenza antiviral medication0.587552
influenza virus infection0.608575
previous influenza seasons0.569391
self-rated health0.514967
vaccination status0.553218
influenza patients0.575421
seasonal influenza vaccine0.803831
influenza illness0.599304
pH1N1 influenza virus0.619406
seasonal influenza vaccines0.606267
Flu VE Network0.512742
2013-14 influenza vaccine0.585044
acute respiratory illness0.586374
influenza vaccine0.906488
influenza activity0.628686
influenza vaccines0.610865
seasonal influenza0.81736
patient vaccination status0.518633
influenza virus infections0.579437
influenza vaccination0.699514
subtyped influenza0.55321
persons0.534299
medical visits0.508589
influenza vaccine effectiveness0.663366
influenza vaccine locator0.588395
annual seasonal influenza0.557496
Influenza Division0.541527
influenza viruses0.711209
annual influenza vaccination0.633162
study site0.53225
Early antiviral treatment0.532211
influenza virus0.678937
predominant influenza virus0.563625
illness onset0.61173
influenza season vaccination0.614208
influenza cases0.556867
influenza diagnostic tests0.565715
CLICK HERE
4522 Centers for Disease Control and Prevention Html en Reconstruction of the 1918 Influenza Pandemic Virus CDC researchers and their colleagues have successfully reconstructed the influenza virus that caused the 1918-19 flu pandemic, which killed as many as 50 million people worldwide.
1918-like H1N1 virus0.644858
Armed Forces Institute0.619031
Biosafety Committee review0.617046
contemporary human influenza0.657081
influenza subtype0.614838
gene segments0.611987
CDC0.644074
current annual influenza0.641234
Involving Noncontemporary Human0.609267
human influenza viruses0.777393
CDC/NIH publication Biosafety0.612496
Laboratory Work Involving0.619515
pandemic influenza viruses0.717498
virus gene products0.62821
Animal Biosafety Level0.622853
similar pandemic virus0.696797
candidate reference virus0.64064
Work Involving Noncontemporary0.61704
Technical Advisory Committee0.609277
influenza research0.611073
HHS select agents0.617192
pandemic viruses0.625929
animal influenza viruses0.657335
current influenza vaccine0.683485
Toxins Technical Advisory0.610183
1918-like virus0.628718
Influenza experts0.613615
Interim CDC-NIH Recommendation0.609971
pandemic influenza virus0.869793
Biosafety Level Laboratory0.673623
pandemic influenza strain0.663971
antiviral drugs0.618323
biosafety level0.763779
select agent program0.613451
select agent0.642301
new influenza virus0.698591
similar virus0.620906
Influenza Pandemic Virus0.799057
influenza viruses0.80971
Intra-governmental Select Agents0.615167
replication competent forms0.607386
influenza virus0.984334
Level Laboratory Work0.62583
Noncontemporary Human Influenza0.688759
biosafety levels0.632484
appropriate biosafety measures0.606356
select agents0.638178
CLICK HERE
5134 Centers for Disease Control and Prevention Html en Alaska Activities to Prevent HAIs null
MPEG0.446113
funding0.634686
monthly update0.806007
email address0.973252
different file formats0.743548
Affordable Care Act0.755504
Epidemiology0.597099
recent work0.786869
PDF0.439171
infectious disease0.830694
PPT0.456191
Laboratory Capacity0.936956
Infectious Diseases0.944175
DOC0.444472
page0.491246
ELC0.644161
CLICK HERE
7014 Centers for Disease Control and Prevention Html en Section 906 of the Federal Food, Drug, and Cosmetic Act -General Provisions Respecting Control of Tobacco Products null
extent0.524934
benefits0.519782
amendment0.524802
manufacturing restrictions0.640632
access0.521102
controls0.518659
Secretary0.629003
methods0.518721
pesticide chemical residues0.707918
protection0.541398
advertising0.542153
distribution0.521184
packing0.519366
type0.51879
subparagraph0.518899
current good manufacturing0.685198
hazard analysis0.605587
public health0.819442
tolerance0.521388
Constitution0.51898
tobacco product0.976857
process0.518559
accordance0.523772
control point methodology0.689023
testing0.518707
nonusers0.519695
finding0.519981
raw tobacco0.700159
preproduction design validation0.703461
respect0.521778
users0.519711
population0.518898
manufacture0.518621
sale0.5212
risks0.520163
performance0.518528
regulation0.618136
regulations0.54742
General0.545898
facilities0.518675
account0.519623
CLICK HERE
7071 Centers for Disease Control and Prevention Html en Global Health - Argentina null
Content source0.422709
HHS0.297574
list Skip0.74332
endorsement0.291872
CDC0.271556
non-federal site0.4688
Notice0.270187
sponsors0.241885
page options Skip0.947337
information0.241652
employees0.242118
CLICK HERE
8969 Centers for Disease Control and Prevention Html en Develop SMART Objectives - Evaluate a CoP - Resource Kit null
additional questions0.503054
important outcomes0.500634
practice0.487491
following table0.614962
activity0.425727
CoP0.792729
Communities0.460752
new products0.497955
table lists questions0.603483
CoP collaborations0.563442
new ideas0.50132
swot analysis0.606231
constraints0.44982
measurement0.422094
CoPs0.569176
CoP translate objectives0.732678
SWOT Analysis Tool0.596905
timeframe0.428134
Numbers0.422117
standard evaluation0.498776
Leaders0.487671
strong action verbs0.600633
SMART Objectives Template0.840169
external factors0.499543
smart objectives0.93171
sample questions0.494425
public health0.508444
goals0.558997
limitations0.421943
means0.442012
sample evaluation objectives0.626681
following questions0.525654
cost0.421924
strategies0.42319
time frame0.505979
Resources section0.503998
change0.422694
CoP environment0.565499
time-based objectives0.556656
resources0.513719
objective lead0.56163
innovations0.442146
Innovation Tracking Tool0.762714
activities0.475696
SMART ones0.52835
evaluation process0.494961
Concrete0.423927
CLICK HERE
10672 Centers for Disease Control and Prevention Html en VX - Nerve Agent'First Hours The CERC training program educates people on the principles and application of crisis and emergency risk communication when responding to a public health emergency.
MPEG0.378858
search0.263099
PDF0.261307
PPT0.446092
DOC0.368812
information0.262482
different file formats0.938484
page0.276773
CLICK HERE
10713 Centers for Disease Control and Prevention Html en Short and Extended Messages'Smallpox'First Hours The CERC training program educates people on the principles and application of crisis and emergency risk communication when responding to a public health emergency.
MPEG0.378858
search0.263099
PDF0.261307
PPT0.446092
DOC0.368812
information0.262482
different file formats0.938484
page0.276773
CLICK HERE
11936 Centers for Disease Control and Prevention Html en Incidence of Hansen's Disease - United States,1994-2011 Leisha Nolen, MD, PhD1, Dana Haberling, MSPH1, David Scollard, MD, PhD2, Richard Truman, PhD2, Alfonso Rodriguez-Lainz, PhD, DVM3, Laura Blum, MPH4, David Blaney, MD1 (Author affiliations at end of text).
rate trends0.439085
foreign-born persons0.759199
new HD0.488252
symptom onset0.506062
Leisha Nolen0.45237
normal incubation period0.44637
severely debilitating disease0.453015
Zoonotic Infectious Diseases0.438041
HD morbidity0.494459
chronic skin disorders0.441193
Federated States0.435799
highest rate0.477108
World Health Organization0.444454
HD trends0.491922
diagnosis0.531326
annual incidence0.460878
primary care clinicians0.443494
symptoms0.470365
chronic skin conditions0.476336
Delayed diagnosis0.433013
lower rate0.439075
HD patients0.480349
U.S.-born persons0.567173
United States0.922675
median delay0.460929
maculopapular skin lesions0.445885
reddish skin patches0.448828
new diagnoses0.494303
U.S. Census Bureau0.475721
mean period0.449999
Current Population Survey0.445763
rate0.521523
annual incidence rate0.460436
cases0.461578
population estimates0.442126
American Community Survey0.444071
rate ratios0.440931
newly diagnosed HD0.521687
average annual rate0.485037
early diagnosis0.433526
HD diagnosis0.525356
bacterium Mycobacterium leprae0.451902
average rate0.439634
higher rate0.437998
public health problem0.4451
1994–19960.435371
HD0.748074
M. leprae0.443956
CLICK HERE
15451 Centers for Disease Control and Prevention Html en Questions About Zika Information on Zika virus. Provided by the U.S. Centers for Disease Control and Prevention.
mosquito bites0.493746
Zika infection0.518209
recent travel0.470534
Zika virus0.803525
territorial health departments0.465468
severe birth defects0.470147
recent Zika virus0.522381
muscle pain0.465468
Zika prevention page0.493365
pregnant women0.587849
Zika-related pregnancy complications0.466171
red eyes0.46648
past Zika infection0.512496
-registered insect repellents0.46674
EPA-registered insect repellents0.465836
Zika virus disease0.578854
current Zika outbreaks0.492886
insect repellents0.50818
symptoms0.591955
Aedes albopictus0.486008
insect repellent0.468592
Zika virus outbreak0.50815
Zika active transmission0.495198
infected Aedes species0.50514
cdc zika travel0.615028
sex partners0.513036
United States0.500827
future Zika infections0.497775
Local mosquito-borne spread0.464779
Zika virus infection0.621486
mild symptoms0.554865
Zika0.920864
zika travel notice0.61047
severe brain defects0.540211
birth defect0.477736
Zika stays0.468528
following ingredients0.46413
sexual transmission0.513538
joint pain0.466857
bites0.515022
people0.505384
birth defects0.472204
infected mosquito0.488588
lemon eucalyptus0.509649
healthcare provider0.510388
Zika cautionary areas0.499449
risk0.57936
Zika symptoms0.498486
Zika virus testing0.516437
CLICK HERE

 

 

 

Terms of Use | Privacy Policy
©2017 ARCHES Technology. All Rights Reserved.